1
|
Steuer CE, El-Deiry M, Parks JR, Higgins
KA and Saba NF: An update on larynx cancer. CA Cancer J Clin.
67:31–50. 2017. View Article : Google Scholar : PubMed/NCBI
|
2
|
Liu Y, Zhao Q, Ding G, Zhu Y, Li W and
Chen W: Incidence and mortality of laryngeal cancer in China,
2008–2012. Chin J Cancer Res. 30:299–306. 2018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Graboyes EM, Zhan KY, Garrett-Mayer E,
Lentsch EJ, Sharma AK and Day TA: Effect of postoperative
radiotherapy on survival for surgically managed pT3N0 and pT4aN0
laryngeal cancer: Analysis of the national cancer data base.
Cancer. 123:2248–2257. 2017. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sessions DG, Lenox J, Spector GJ, Newland
D, Simpson J, Haughey BH and Chao KSC: Management of T3N0M0 glottic
carcinoma: Therapeutic outcomes. Laryngoscope. 112:1281–1288. 2002.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Spector GJ, Sessions DG, Lenox J, Newland
D, Simpson J and Haughey BH: Management of stage IV glottic
carcinoma: Therapeutic outcomes. Laryngoscope. 114:1438–1446. 2004.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Kim SH, Lee YS, Kwon M, Kim JW, Jong-Lyel
R, Choi SH, Kim SY, Lee SW and Nam SY: Adjuvant role of radiation
therapy for locally advanced laryngeal cancer without pathological
lymph node metastasis. Acta Otolaryngol. 136:703–710. 2016.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Laccourreye O, Hans S, Borzog-Grayeli A,
Maulard-Durdux C, Brasnu D and Housset M: Complications of
postoperative radiation therapy after partial laryngectomy in
supraglottic cancer: A long-term evaluation. Otolaryngol Head Neck
Surg. 122:752–757. 2000. View Article : Google Scholar : PubMed/NCBI
|
8
|
Pfister DG, Spencer S, Adelstein D, Adkins
D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ,
et al: Head and neck cancers, version 2.2020, NCCN clinical
practice guidelines in oncology. J Natl Compr Cancer Netw.
18:873–898. 2020. View Article : Google Scholar : PubMed/NCBI
|
9
|
Chen AY and Halpern M: Factors predictive
of survival in advanced laryngeal cancer. Arch Otolaryngol Head
Neck Surg. 133:1270–1276. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Grover S, Swisher-McClure S, Mitra N, Li
J, Cohen RB, Ahn PH, Lukens JN, Chalian AA, Weinstein GS, O'Malley
BW Jr and Lin A: Total laryngectomy versus larynx preservation for
T4a larynx cancer: Patterns of care and survival outcomes. Int J
Radiat Oncol Biol Phys. 92:594–601. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hoffman HT, Porter K, Karnell LH, Cooper
JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A and Robinson RA:
Laryngeal cancer in the United States: Changes in demographics,
patterns of care, and survival. Laryngoscope. 116:1–13. 2006.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Human D: Declaration of Helsinki. Lancet.
357:2362001. View Article : Google Scholar : PubMed/NCBI
|
13
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhou J, Zhou L, Tao L, Zhang M, Wu H, Chen
X, Li X, Li C and Gong H: Oncologic outcomes of surgical treatment
for T3 glottic laryngeal squamous cell carcinoma. Head Neck.
40:1734–1742. 2018.PubMed/NCBI
|
15
|
Holsinger FC, Tomeh C, Moore MW, Yan W,
Chen C and Laccourreye O: Supracricoid partial laryngectomy with
cricohyoidoepiglottopexy: Surgical technique illustrated in the
anatomy laboratory. Head Neck. 37:906–908. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhu X, Heng Y, Zhou L, Tao L and Zhang M:
A prognostic nomogram for predicting risk of recurrence in
laryngeal squamous cell carcinoma patients after tumor resection to
assist decision making for postoperative adjuvant treatment. J Surg
Oncol. 120:698–706. 2019.PubMed/NCBI
|
17
|
Dziegielewski PT, O'Connell DA, Klein M,
Fung C, Singh P, Mlynarek MA, Fung D, Harris JR and Seikaly H:
Primary total laryngectomy versus organ preservation for T3/T4a
laryngeal cancer: A population-based analysis of survival. J
Otolaryngol Head Neck Surg. 41 (Suppl 1):S56–S64. 2012.PubMed/NCBI
|
18
|
Timmermans AJ, de Gooijer CJ,
Hamming-Vrieze O, Hilgers FJ and van den Brekel MW: T3-T4 laryngeal
cancer in The Netherlands cancer institute; 10-year results of the
consistent application of an organ-preserving/-sacrificing
protocol. Head Neck. 37:1495–1503. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Lechien JR, Maniaci A, Hans S, Iannella G,
Fakhry N, Mayo-Yáñez M, Ayad T, Mannelli G and Chiesa-Estomba CM:
Epidemiological, clinical and oncological outcomes of young
patients with laryngeal cancer: A systematic review. Eur Arch
Otorhinolaryngol. 2:10.1007/s00405–022-07466-9. 2022.
|
20
|
Forastiere AA, Ismaila N, Lewin JS, Nathan
CA, Adelstein DJ, Eisbruch A, Fass G, Fisher SG, Laurie SA, Le QT,
et al: Use of larynx-preservation strategies in the treatment of
laryngeal cancer: American society of clinical oncology clinical
practice guideline update. J Clin Oncol. 36:1143–1169. 2018.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Hinni ML, Salassa JR, Grant DG, Pearson
BW, Hayden RE, Martin A, Christiansen H, Haughey BH, Nussenbaum B
and Steiner W: Transoral laser microsurgery for advanced laryngeal
cancer. Arch Otolaryngol Head Neck Surg. 133:1198–1204. 2007.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Mannelli G, Lazio MS, Luparello P and
Gallo O: Conservative treatment for advanced T3-T4 laryngeal
cancer: Meta-analysis of key oncological outcomes. Eur Arch
Otorhinolaryngol. 275:27–38. 2018. View Article : Google Scholar : PubMed/NCBI
|
23
|
Ko HC, Harari PM, Chen S, Wieland AM, Yu
M, Baschnagel AM, Kimple RJ and Witek ME: Survival outcomes for
patients with T3N0M0 squamous cell carcinoma of the glottic larynx.
JAMA Otolaryngol Head Neck Surg. 143:1126–1133. 2017. View Article : Google Scholar : PubMed/NCBI
|
24
|
Nguyen-Tan PF, Le QT, Quivey JM, Singer M,
Terris DJ, Goffinet DR and Fu KK: Treatment results and prognostic
factors of advanced T3-4 laryngeal carcinoma: The University of
California, San Francisco (UCSF) and Stanford University hospital
(SUH) experience. Int J Radiat Oncol Biol Phys. 50:1172–1180. 2001.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Hinerman RW, Morris CG, Amdur RJ, Lansford
CD, Werning JW, Villaret DB and Mendenhall WM: Surgery and
postoperative radiotherapy for squamous cell carcinoma of the
larynx and pharynx. Am J Clin Oncol. 29:613–621. 2006. View Article : Google Scholar : PubMed/NCBI
|
26
|
Machtay M, Moughan J, Trotti A, Garden AS,
Weber RS, Cooper JS, Forastiere A and Ang KK: Factors associated
with severe late toxicity after concurrent chemoradiation for
locally advanced head and neck cancer: An RTOG analysis. J Clin
Oncol. 26:3582–3589. 2008. View Article : Google Scholar : PubMed/NCBI
|
27
|
Nguyen NP, Moltz CC, Frank C, Millar C,
Smith HJ, Dutta S, Nguyen PD, Nguyen LM, Lemanski C, Ludin A, et
al: Effectiveness of the cough reflex in patients with aspiration
following radiation for head and neck cancer. Lung. 185:243–248.
2007. View Article : Google Scholar : PubMed/NCBI
|
28
|
Nguyen NP, Smith HJ, Dutta S, Alfieri A,
North D, Nguyen PD, Lee H, Martinez T, Lemanski C, Ludin A, et al:
Aspiration occurence during chemoradiation for head and neck
cancer. Anticancer Res. 27:1669–1672. 2007.PubMed/NCBI
|
29
|
Foote RL, Foote RT, Brown PD, Garces YI,
Okuno SH and Strome SE: Organ preservation for advanced laryngeal
carcinoma. Head Neck. 28:689–696. 2006. View Article : Google Scholar : PubMed/NCBI
|
30
|
Pfister DG, Laurie SA, Weinstein GS,
Mendenhall WM, Adelstein DJ, Ang KK, Clayman GL, Fisher SG,
Forastiere AA, Harrison LB, et al: American Society of Clinical
Oncology clinical practice guideline for the use of
larynx-preservation strategies in the treatment of laryngeal
cancer. J Clin Oncol. 24:3693–3704. 2006. View Article : Google Scholar : PubMed/NCBI
|
31
|
Cosetti M, Yu GP and Schantz SP: Five-year
survival rates and time trends of laryngeal cancer in the US
population. Arch Otolaryngol Head Neck Surg. 134:370–379. 2008.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Sanguineti G, Vidiri A and Pellini R: Is
postoperative radiotherapy routinely indicated after total
laryngectomy for pT3N0-1 supraglottic carcinoma? Oral Oncol.
107:1048252020. View Article : Google Scholar : PubMed/NCBI
|
33
|
Lin CC, Fedewa SA, Prickett KK, Higgins KA
and Chen AY: Comparative effectiveness of surgical and nonsurgical
therapy for advanced laryngeal cancer. Cancer. 122:2845–2856. 2016.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Lee M, Buchanan MA, Riffat F and Palme CE:
Complications after CO2 laser surgery for early glottic cancer: An
institutional experience. Head Neck. 38 (Suppl 1):E987–E990. 2016.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Richard JM, Sancho-Garnier H, Pessey JJ,
Luboinski B, Lefebvre JL, Dehesdin D, Stromboni-Luboinski M and
Hill C: Randomized trial of induction chemotherapy in larynx
carcinoma. Oral Oncol. 34:224–228. 1998. View Article : Google Scholar : PubMed/NCBI
|
36
|
Patel SA, Qureshi MM, Dyer MA, Jalisi S,
Grillone G and Truong MT: Comparing surgical and nonsurgical
larynx-preserving treatments with total laryngectomy for locally
advanced laryngeal cancer. Cancer. 125:3367–3377. 2019. View Article : Google Scholar : PubMed/NCBI
|